What is the recommended albumin infusion dose and administration rate for an adult with severe hypoalbuminemia (serum albumin <2 g/dL)?

Albumin Infusion Dose for Severe Hypoalbuminemia

For adults with severe hypoalbuminemia (serum albumin <2 g/dL), administer 25% albumin at a dose of 50-75 g daily for adults (25 g for children), infused at a rate not exceeding 2 mL/minute to avoid circulatory overload and pulmonary edema. 1

Dosing Recommendations

Standard Dosing Protocol

The FDA-approved dosing for severe hypoalbuminemia is clear and specific 1:

• Adults: 50-75 g daily of 25% albumin
• Children: 25 g daily
• Infusion rate: Maximum 2 mL/minute (critical to prevent circulatory complications)
• Target: Maintain plasma albumin ≥2.5 g/dL (equivalent to plasma oncotic pressure of 20 mm Hg) 1

Administration Method

Continuous infusion is superior to bolus administration in critically ill hypoalbuminemic patients. A pediatric study demonstrated that continuous 24-hour infusion resulted in a 34% increase in blood albumin concentration after 24 hours, compared to only 14% with 4-hour bolus dosing 2. The half-life of albumin given as bolus is remarkably short (4.6 hours), whereas continuous infusion maintains steady-state levels more effectively 2.

Preparation Options

25% albumin may be administered 1:

• Undiluted (preferred for severe hypoalbuminemia)
• Diluted in 0.9% sodium chloride or 5% dextrose
• For sodium restriction: Use only undiluted or diluted in 5% dextrose

Critical Considerations

When Albumin May Be Beneficial

The evidence supports albumin use primarily in specific contexts, not for routine hypoalbuminemia correction:

Strong evidence (from 2024 guidelines) 3:

• Spontaneous bacterial peritonitis in cirrhosis: 1.5 g/kg on day 1, then 1.0 g/kg on day 3 (reduces kidney impairment and mortality)
• Large-volume paracentesis: 6-8 g per liter of ascitic fluid removed (prevents circulatory dysfunction)

Moderate evidence:

• Severe acute pancreatitis with hypoalbuminemia: Doses >100 g within the first week may reduce mortality 4, 5
• Refractory edema despite maximal diuretics when albumin <2 g/dL 1, 6

Important Warnings

Albumin administration carries significant risks that must be weighed carefully:

1. Increased mortality risk in sepsis: A 2025 international study of 1.1 million patients found albumin supplementation in septic patients with hypoalbuminemia increased 30-day mortality (HR 1.800), shock, heart failure, and pulmonary edema 7. This contradicts older assumptions about albumin's benefit in sepsis.

2. No benefit in general hypoalbuminemia: A 1997 RCT demonstrated that albumin infusion in hypoalbuminemic patients receiving TPN did not improve morbidity or mortality despite raising serum levels 8. The high catabolic rate (17-20 g/day) means much of the infused albumin is simply degraded 8.

3. Circulatory overload: 25% albumin is hyperoncotic and expands plasma volume by 3-4 times the infused volume 1. Infusion rates >2 mL/minute risk pulmonary edema, particularly in patients with normal blood volumes 1.

4. Cardiovascular surgery: The largest trial (1,386 patients) found albumin increased bleeding, resternotomy, and infection rates compared to crystalloids 3.

Practical Algorithm

Step 1: Identify the underlying cause

• Cirrhosis with complications → Use albumin per specific protocols above
• Sepsis/septic shock → Avoid routine albumin (associated with worse outcomes) 7
• Severe acute pancreatitis → Consider albumin if albumin <3 g/dL (30 g/day for 2-3 days) 5
• General critical illness/malnutrition → Do not use albumin (no mortality benefit) 8, 9

Step 2: If albumin is indicated

• Start with 50-75 g daily (25% solution)
• Administer as continuous infusion over 24 hours (preferred) or slow infusion over 3-6 hours
• Never exceed 2 mL/minute infusion rate
• Monitor for signs of volume overload (pulmonary edema, heart failure)

Step 3: Duration and monitoring

• Target serum albumin ≥2.5 g/dL 1
• For severe acute pancreatitis: Consider total dose >100 g in first week 4
• Reassess daily; discontinue if no clinical benefit or volume overload develops
• Do not use albumin as nutritional support - initiate proper enteral/parenteral nutrition instead 1

Key Pitfalls to Avoid

• Do not infuse rapidly: Rates >2 mL/minute cause circulatory embarrassment 1
• Do not use in dehydrated patients: Give crystalloids first or use 5% albumin instead 1
• Do not use for routine hypoalbuminemia: Evidence shows no benefit and potential harm 8, 7
• Do not exceed physiologic albumin levels: Total dose should not exceed 2 g/kg body weight in absence of active bleeding 1
• Avoid in sepsis without specific indication: Recent large-scale data shows increased mortality 7

The 2024 international guidelines emphasize that albumin should not be used routinely for hypoalbuminemia correction 3. Its use should be restricted to evidence-based indications, primarily liver disease complications, with careful attention to infusion rates and volume status.